Spinal Fusion Market Size was valued at USD 9.8 Billion in 2022. The Spinal Fusion Market industry is projected to grow from USD 10.3 Billion in 2023 to USD 16.27 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.80% during the forecast period (2023 - 2032). The Increasing Road accidents, rise in the advancements in surgical procedure, and surge in healthcare expenditure, rise in awareness towards treatment are expected to be significant market drivers for the Spinal Fusion Market.
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Rising number of aging population and growing spine disorders are driving the market growth
Market CAGR for Spinal Fusion is driven by the rising number of aging population and growing spine disorders. The population is undergoing a rapid aging process, driven by declining birth rates and increased life expectancy. This demographic shift towards an older population underscores a growing need for addressing spine disorders associated with old age. According to the World Health Organization's May 2021 report, it is projected that by 2030, 1 out of every 6 individuals worldwide will be 60 years old or older. The number of people in this age group is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. Furthermore, by 2050, the population of individuals aged 60 and above is anticipated to double, reaching 2.1 billion. During the same period, the number of people aged 80 and above is forecasted to triple, reaching 426 million. These demographic changes, combined with prolonged exposure to risk factors, contribute to an increased incidence of spine disorders, often requiring surgical intervention. Therefore, the market is likely to be significantly influenced by the rising aging population and the concurrent increase in spine disorders.
Additionally, a study published in May 2022 titled "Spinal Cord Injuries" highlights that annually, between 250,000 and 500,000 people worldwide experience a spinal cord injury, with the majority resulting from preventable factors such as violence and car accidents. In the United States alone, approximately 17,000 new cases of spinal cord injury (SCI) are reported each year, and an estimated 282,000 people are living with SCI. Men, particularly in the age group of 16 to 30 years old, have the highest risk of SCI caused by sports injuries. This high incidence of spinal cord injuries is expected to drive the demand for spinal fusion devices in the coming years. Furthermore, the increasing preference for minimally invasive surgeries, driven by various benefits, is contributing to the overall growth of the market. As a result, it is anticipated that throughout the projection period, demand for the Spinal Fusion Market will increase due to the rising number of aging population and growing spine disorders. Thus, driving the Spinal Fusion Market revenue.
The Spinal Fusion Market segmentation, based on Product includes Interbody Cages, Pedicle Screws and Rods, and Spinal Fusion Plates. The Interbody Cages segment dominated the market, accounting for 58% of market revenue. One potential benefit of utilizing an anterior interbody cage is the ability to accommodate a larger implant, consequently reducing the risk of failed fusion (pseudoarthrosis) and facilitating improved expansion of bony spaces for spinal nerves. Cylindrical cages are typically employed when disc space height is compromised or diminished due to disc degeneration or wear. Although threaded cages contribute to enhanced fusion rates compared to their non-threaded counterparts, it's important to note that the presence of threads may concurrently reduce the stability of the cage
The Spinal Fusion Market segmentation, based on Procedure includes Posterolateral Fusion and Interbody Fusion. The Interbody Fusion segment dominated the market, accounting for 58% of market revenue. Interbody fusion exhibits positive clinical outcomes and maintains relatively low complication rates, fostering confidence among surgeons and patients alike. The established success of this technique in treating conditions like degenerative disc disease, spondylolisthesis, and spinal stenosis solidifies its dominant position within the market.
The Spinal Fusion Market segmentation, based on Users includes Hospitals, Specialty Clinics, and Ambulatory Surgical Centres. The Hospitals segment dominated the market, accounting for 60% of market revenue (5.8 Billion). The expansion of the patient pool and increasing demand for streamlined, efficient surgeries with shorter recovery times and reduced hospital stays are pivotal factors propelling the growth of this segment within the spinal fusion market. The presence of advanced technologies and a surge in demand for minimally invasive surgical procedures further contribute to the segment's growth.
Figure 1: Spinal Fusion Market, by End-User, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The anticipated expansion of the Spinal Fusion market in North America can be attributed to several key factors. Within North America, the United States is poised to maintain the largest market share. The current dominance of the United States in the spinal surgery devices market is projected to persist in the forthcoming years. This enduring leadership is driven by the continual increase in the number of Americans experiencing lower back pain and other spinal disorders annually. According to the 2020 report from the National Spinal Cord Injury Statistical Center, the United States witnesses an annual incidence of approximately 54 cases of spinal cord injury (SCI) per one million people, translating to around 17,810 new SCI cases each year, considering the current population of 329 million. Consequently, the escalating burden of spinal cord injuries is expected to propel the demand for spinal fusion devices, contributing to market growth.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: SPINAL FUSION MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe's Spinal Fusion Market accounts for the second-largest market share as the European region exhibits a considerable proportion of its population in the geriatric category compared to the overall demographic composition. Notably, spinal surgeries are predominantly performed on individuals aged 65 and above. As an illustration, a September 2021 article published by Europe PMC highlighted the high prevalence and disabling nature of neurological conditions in the elderly population. Italy, in particular, has experienced a notable aging trend, anticipating an upward trajectory in the incidence, prevalence, and disability associated with these neurological conditions. Additionally, the market in the region is being driven by technological advancements introduced by key industry players. Further, the German Spinal Fusion Market held the largest market share, and the UK Spinal Fusion Market was the fastest-growing market in the European region
The Asia-Pacific Spinal Fusion Market is expected to grow at the fastest CAGR from 2023 to 2032. The surge in the incidence of spinal disorders and the overall increase in healthcare expenditure are driving factors for the growth observed in this market. Additionally, the rapid aging population and the cost-effectiveness of spinal procedures in countries like India, in comparison to developed nations such as the U.S., have contributed to an escalating demand for spinal implants. In India, spinal surgeries are conducted across more than 2,000 hospitals, with complex procedures, including microscopic spine surgery, being carried out in at least 500 specialized spinal surgery and super specialty hospitals. According to a February 2016 article in the "Tohoku Journal of Experimental Medicine," approximately 23.1% of the Japanese population was aged above 65, and 11.4% were aged above 75 by the end of 2010. The same study reported that in 2012, more than 70% of the patients with lumbar spinal stenosis (LSS) and cervical myelopathy were above 70 years of age. Moreover, China’s Spinal Fusion Market held the largest market share, and the Indian Spinal Fusion Market was the fastest-growing market in the Asia-Pacific region.
Spinal Fusion Market Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development to expand their product lines, which will help the Spinal Fusion market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Spinal Fusion industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Spinal Fusion industry to benefit clients and increase the market sector. In recent years, the Spinal Fusion industry has offered some of the most significant advantages to patients suffering from spinal disorders and practitioners conducting spinal surgeries. Major players in the Spinal Fusion Market, including Zimmer Biomet Holdings, Inc., Stryker Corporation, Inc., Exactech, Inc., Medtronic Plc, Johnson & Johnson Services, Inc (Depuy Synthes), Wenzel Spine, Inc., Centinel Spine, Inc., Spineart Geneva SA, K2M, Inc., MicroPort Scientific Corporation are attempting to increase market demand by investing in research and development operations.
Johnson & Johnson (J&J) is engaged in the research, development, manufacturing, and sale of pharmaceutical products, medical devices, and consumer goods. The company offers a range of pharmaceuticals addressing immune diseases, cancer, neurological disorders, infectious diseases, cardiovascular issues, and metabolic conditions. In addition, J&J provides consumer products spanning oral care, baby care, beauty, over-the-counter (OTC) medicines, women's health, and wound care. Their medical devices cover cardiovascular, orthopedic, neurovascular care, general surgery, and vision care. J&J distributes pharmaceutical and medical products to retailers, wholesalers, healthcare professionals, and hospitals. Consumer products are made available through retail outlets and distributors. The company operates in regions including the US, Europe, Asia-Pacific, Africa, and the Western Hemisphere (excluding the US), with its headquarters located in New Brunswick, New Jersey, USA. In a strategic move announced in September 2018, Johnson & Johnson Medical Devices Companies completed the acquisition of Emerging Implant Technologies GmbH (EIT). This acquisition aims to enhance J&J's portfolio in both minimally invasive and open spinal fusion surgery. The primary objective is to offer a wider range of interbody solutions to surgeons, empowering them to deliver improved treatment options for patients.
Medtronic Plc (formerly Medtronic Inc.) is a leading medical technology company specializing in the design, development, manufacturing, and marketing of medical devices and solutions. The company's product range encompasses treatments for heart valve disorders, heart failure, coronary artery diseases, aortic, peripheral vascular, venous renal, and neurological diseases, as well as spine and musculoskeletal disorders. Additionally, Medtronic addresses diseases of the ear, nose, and throat, and provides biologic solutions for the orthopedic and dental markets. Medtronic serves a diverse customer base, including hospitals, third-party healthcare providers, clinics, governmental healthcare programs, distributors, and group purchasing organizations across Asia Pacific, Europe, the Americas, the Middle East, and Africa. With its headquarters in Dublin, Ireland, Medtronic is actively involved in acquisitions, alongside companies like Stryker Corporation, as part of its strategic initiatives to enhance its position in the spine market. This approach aims to improve their product portfolios and presence.
Key companies in the Spinal Fusion Market include
Spinal Fusion Industry Developments
June 2022: In June 2022, Camber Spine announced the progression into the subsequent stage of the nationwide rollout for its SPIRA-P posterior lumbar spacer. Additionally, the company has recently brought to market its SPIRA-T oblique posterior lumbar spacer.
June 2022: In June 2022, the United States Food and Drug Administration (FDA) issued 510K clearance for Aurora Spine's DEXA SOLO-L anterior lumbar interbody fusion device (ALIF)
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 9.8 Billion |
| Market Size 2023 | USD 10.3 Billion |
| Market Size 2032 | USD 16.27 Billion |
| Compound Annual Growth Rate (CAGR) | 5.80% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Procedure, End-User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Zimmer Biomet Holdings, Inc., Stryker Corporation, Inc., Exactech, Inc., Medtronic Plc, Johnson & Johnson Services, Inc (Depuy Synthes), Wenzel Spine, Inc., Centinel Spine, Inc., Spineart Geneva SA, K2M, Inc., MicroPort Scientific Corporation |
| Key Market Opportunities | · Emergence of Minimally Invasive Surgery in Spinal Fusion |
| Key Market Dynamics | · Rise in incidences of spinal disorders |
Frequently Asked Questions (FAQ) :
The Spinal Fusion Market size was valued at USD 9.8 Billion in 2022.
The Spinal Fusion Market is projected to grow at a CAGR of 5.80% during the forecast period, 2023-2032.
North America had the largest share of the market
The key players in the market are Zimmer Biomet Holdings, Inc., Stryker Corporation, Inc., Exactech, Inc., Medtronic Plc, Johnson & Johnson Services, Inc (Depuy Synthes), Wenzel Spine, Inc., Centinel Spine, Inc., Spineart Geneva SA, K2M, Inc., MicroPort Scientific Corporation
The Interbody Cages segment dominated the market in 2022.
The Hospitals segment had the largest share in the market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
